<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1870-7203</journal-id>
<journal-title><![CDATA[Acta médica Grupo Ángeles]]></journal-title>
<abbrev-journal-title><![CDATA[Acta méd. Grupo Ángeles]]></abbrev-journal-title>
<issn>1870-7203</issn>
<publisher>
<publisher-name><![CDATA[Grupo Ángeles, Servicios de Salud]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1870-72032025000100028</article-id>
<article-id pub-id-type="doi">10.35366/119345</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Prevalencia de adenomiosis en pacientes expuestas a hiperestrogenismo con diagnóstico de miomatosis uterina, de acuerdo a la teoría de la invaginación como etiología de adenomiosis]]></article-title>
<article-title xml:lang="en"><![CDATA[Prevalence of adenomyosis in patients exposed to hyperestrogenism with a diagnosis of uterine myomatosis, according to the theory of invagination as an etiology of adenomyosis]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[López Lee]]></surname>
<given-names><![CDATA[César A]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
<xref ref-type="aff" rid="A a"/>
<xref ref-type="aff" rid="A1"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[González Baltazar]]></surname>
<given-names><![CDATA[Mixtty]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Guzmán Valdivia]]></surname>
<given-names><![CDATA[Gilberto]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Arredondo Merino]]></surname>
<given-names><![CDATA[Rodrigo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad La Salle Facultad Mexicana de Medicina Hospital Angeles Pedregal]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad La Salle Facultad Mexicana de Medicina Hospital Angeles Pedregal]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Universidad La Salle México Facultad Mexicana de Medicina ]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,Hospital Angeles Pedregal Servicio de Ginecología y Obstetricia ]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>México</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>03</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>03</month>
<year>2025</year>
</pub-date>
<volume>23</volume>
<numero>1</numero>
<fpage>28</fpage>
<lpage>31</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S1870-72032025000100028&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S1870-72032025000100028&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S1870-72032025000100028&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen:  Introducción:  el sangrado uterino anormal es la primera causa de consulta ginecológica en edad fértil. Tiene varias etiologías (PALM-COEIN) y una de las más importantes son miomatosis y adenomiosis, en donde la relación es el hiperestrogenismo.  Objetivo:  demostrar la relación de miomatosis uterina y adenomiosis como consecuencia de la misma etiología, el hiperestrogenismo.  Material y métodos:  diseño retrospectivo, observacional, descriptivo y de tipo casos y controles, en el que se recopilaron 655 expedientes clínicos de pacientes sometidas a histerectomía abdominal con resultado de patología postquirúrgico. Los procedimientos se llevaron a cabo en el periodo del 1 de marzo de 2017 al 1 de marzo de 2019, en un hospital privado de tercer nivel, Hospital Angeles Pedregal en la Ciudad de México, México.  Resultados:  encontramos que la prevalencia de miomatosis uterina y adenomiosis en dos años en el Hospital Angeles Pedregal es de 31.9%.  Conclusiones:  la etiología de la invaginación secundaria a hiperestrogenismo se relaciona con ambas patologías; se registró una prevalencia de ambas en 31.9% de las pacientes estudiadas. La edad o las gestas no fueron significativas durante el estudio.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract:  Introduction:  abnormal uterine bleeding is the first cause of gynecological consultation in fertile age. It has several etiologies (PALM COEIN) and one of the most important is myomatosis and adenomyosis, where the relationship is hyperestrogenism.  Objective:  demonstrate the relationship between uterine myomatosis and adenomyosis as a consequence of the same etiology, hyperestrogenism.  Material and methods:  retrospective, observational, descriptive and case-control design, in which 655 clinical records of patients undergoing abdominal hysterectomy with post-surgical pathology results were collected. The procedures were carried out in the period from March 1, 2017 to March 1, 2019, in a private tertiary hospital, Hospital Angeles Pedregal in Mexico City, Mexico.  Results:  we found that the prevalence of uterine myomatosis and adenomyosis in two years at the Angeles Pedregal Hospital is 31.9%.  Conclusions:  the etiology of intussusception secondary to hyperestrogenism is related to both pathologies, demonstrating a prevalence of both in 31.9% of the patients studied. Age or pregnancies were not significant during the study.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[hiperestrogenismo]]></kwd>
<kwd lng="es"><![CDATA[adenomiosis]]></kwd>
<kwd lng="es"><![CDATA[miomatosis uterina]]></kwd>
<kwd lng="en"><![CDATA[hyperestrogenism]]></kwd>
<kwd lng="en"><![CDATA[adenomyosis]]></kwd>
<kwd lng="en"><![CDATA[uterine myomatosis]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fernández-Díaz]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
</person-group>
<source><![CDATA[Correlación entre el diagnóstico ecográfico e histopatológico de adenomiosis en pacientes histerectomizadas en el Hospital Nacional Arzobispo Loayza del 2017 al 2021]]></source>
<year>2022</year>
<publisher-name><![CDATA[Handlenet]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bacon]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Abnormal uterine bleeding: current classification and clinical management]]></article-title>
<source><![CDATA[Obstet Gynecol Clin North Am]]></source>
<year>2017</year>
<volume>44</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>179-93</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hernández-Valencia]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Valerio-Castro]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[TerceroValdez-Zúñiga]]></surname>
<given-names><![CDATA[CL]]></given-names>
</name>
<name>
<surname><![CDATA[Barrón-Vallejo]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Luna-Rojas]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Miomatosis uterina: implicaciones en salud reproductiva]]></article-title>
<source><![CDATA[Ginecol Obstet Mex]]></source>
<year>2017</year>
<volume>85</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>611-33</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Taran]]></surname>
<given-names><![CDATA[FA]]></given-names>
</name>
<name>
<surname><![CDATA[Weaver]]></surname>
<given-names><![CDATA[AL]]></given-names>
</name>
<name>
<surname><![CDATA[Coddington]]></surname>
<given-names><![CDATA[CC]]></given-names>
</name>
<name>
<surname><![CDATA[Stewart]]></surname>
<given-names><![CDATA[EA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Characteristics indicating adenomyosis coexisting with leiomyomas: a case-control study]]></article-title>
<source><![CDATA[Hum Reprod]]></source>
<year>2010</year>
<volume>25</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>1177-82</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[García-Solares]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Donnez]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Donnez]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Dolmans]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pathogenesis of uterine adenomyosis: invagination or metaplasia?]]></article-title>
<source><![CDATA[Fertil Steril]]></source>
<year>2018</year>
<volume>109</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>371-9</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Struble]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Reid]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Bedaiwy]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Adenomyosis: a clinical review of a challenging gynecologic condition]]></article-title>
<source><![CDATA[J Minim Invasive Gynecol]]></source>
<year>2016</year>
<volume>23</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>164-85</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Galicia]]></surname>
<given-names><![CDATA[TLN]]></given-names>
</name>
<name>
<surname><![CDATA[Gómez]]></surname>
<given-names><![CDATA[PMG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalencia de adenomiomas y hallazgos asociados en estudios de resonancia magnética de útero en pacientes con miomatosis]]></article-title>
<source><![CDATA[Acta Med]]></source>
<year>2022</year>
<volume>20</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>24-9</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Khalifa]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Abidalla]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Al-Zail]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The significance of pain in leiomyoma with adenomyosis and liomyoma without adenomysis]]></article-title>
<source><![CDATA[Tobruk University Journal of Medical Sciences (TUJMS)]]></source>
<year>2023</year>
<volume>5</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>63-9</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Garcia]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[(2011). Adenomyosis: review of the literature]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Isaacson]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<source><![CDATA[J Minim Invasive Gynecol]]></source>
<year>2011</year>
<volume>18</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>428-37</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Brun]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Creux]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Gauzere]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Randaoharison]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Dallay]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Tratamiento de la adenomiosis]]></article-title>
<source><![CDATA[EMC - Ginecología-Obstetricia]]></source>
<year>2007</year>
<volume>43</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>1-9</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pron]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Cohen]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Soucie]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Garvin]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Vanderburgh]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Bell]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The Ontario Uterine Fibroid Embolization Trial. Part 1. Baseline patient characteristics, fibroid burden, and impact on life]]></article-title>
<source><![CDATA[Fertil Steril]]></source>
<year>2003</year>
<volume>79</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>112-9</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Edwards]]></surname>
<given-names><![CDATA[RD]]></given-names>
</name>
<name>
<surname><![CDATA[Moss]]></surname>
<given-names><![CDATA[JG]]></given-names>
</name>
<name>
<surname><![CDATA[Lumsden]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Wu]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Murray]]></surname>
<given-names><![CDATA[LS]]></given-names>
</name>
<name>
<surname><![CDATA[Twaddle]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Uterine-artery embolization versus surgery for symptomatic uterine fibroids]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>2007</year>
<volume>356</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>360-70</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
